chrisvoncsefalvay/vaers-outcomes huggingface dataset:
at 14 years old, patient received MMRII; This spontaneous report was received from a pediatrician referring to a 14-year-old patient. Information regarding the patient's concurrent conditions, medical history and concomitant therapies was not provided. The patient only ever received an unspecified hepatitis B vaccine when the patient was a baby.   On 27-OCT-2020, the patient received measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), varicella virus vaccine live (oka/merck) (VARIVAX), poliovirus vaccine inactivated (vero) (IPOL) and diphtheria toxoid, pertussis acellular 3-component vaccine, tetanus toxoid (BOOSTRIX) for prophylaxis (strength, dose, frequency, route of administration, lot number and expiration date were not reported for any of the vaccines). The patient was due to receive a total of 9 immunizations including the previously mentioned vaccines; the patient would not agree to receive the remaining immunizations at event time.
6/5/07:  Tdap administered in right deltoid. 6/12/07: Immunization staff notified Employee Health Nurse that employee (patient) called to inquire about her right arm where vaccination was given was still very sore. 6/18/07: Employee exposed to natural gas leak in Public Health Clinic. Employee states she had mild HA and nausea upon waking in am.  Became dizzy, "fuzzy" feeling, HA worsened, tongue thick, and right arm still very sore where vaccine administered. 6/19/07;  Employee calls Employee Health Nurse (EHN)report that HA has worsened, dizzy still, nausea, diarrhea, and tingling in fingers and tongue. (Workman's Compensation Medical Management Group)called by EHN and employee (patient) sent to Doctor's Care. 6/20/07: Follow-up telephone conversation with patient in during which patient stated that she has a blood test for "gas build-up".  Also had a CAT scan to rule out a stroke.  Referred her private MD to follow up on her increased BP (stated never had blood pressure problem before). 6/25/07:  Telephone call from employee's (patient's) supervisor who received a phone call from patient stating she has an appointment so see a neurologist (family physician referral) as she now is experiencing right sided numbness, slurred speech, and difficulty with gait and balance.  Saw Dr.  Instructed patient to take Benedryl 50 mg TIDx3 days, and if symptoms were gas related, they would resolve.  patient's condition worsened during the evening of 6/25/07 per employee's husband who called the neurologist's service, and was advised by Dr. to go to the hospital for admittance. 6/26/07;  Diagnosed with Guillian-Barre. 6/27/07:  Patient admitted to ICU due to breathing difficulties.  Spinal tap and plasma phoresis initiated. 07/30/2007 MRs received for ER visit 6/19/2007 and admit 6/26-7/2/2007. ER visit for c/o headache, numbness of the tongue, hands and fingers, and tingling after being exposed to a gas leak at work.  Impression: Numbness. HTN.  Pt presented to ER again on 6/26/07 with c/o headaches, confusion, progressive generalized weakness, dysphagia, facial weakness, dysarthric speech with tongue weakness. Symptoms progressed so pt was unable to stand and she paresthesias of her feet.   PE significant for bilateral orbicularis oculi, orbicularis oris, and bilateral tongue weakness. Mild vibratory sensory loss in the feet, diffuse areflexia. Txd with plasmapheresis D/C DX: Guillain Barre Syndrome.
This spontaneous report was received from a consumer referring to her 15 year old female daughter. The patient's concomitant medications and medical history were not reported. In January 2017, the patient was vaccinated with GARDASIL 9 (lot #, expiration date, dosage, schedule and route were not reported) for prophylaxis. The patient had not yet received a 2nd dose in the GARDASIL 9 vaccination series. On 2017 the patient was diagnosed with a blood clot (thrombosis). The reporter said that her daughter was under the care of a physician. The outcome of thrombosis was unknown. The causal relationship between GARDASIL 9 and thrombosis was not provided. Upon internal review thrombosis was determined to be a medically significant event.
My Lipase levels went up to 1,495 on Friday (May 21). I was suffering from sharp stomach pains. I've since reduced my food intake and drank a lot of liquids. As of Monday (May 24) my Lipase levels went down to 583.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with the improperly stored doses of GARDASIL 9 (dose and route of administration were not reported) (lot # M028323 and expiration date 26-SEP-2018) for prophylaxis. There were no adverse effects reported. Administered doses of vaccines experienced the temperature excursion between 47 to 77 degrees Fahrenheit for 2 hours 14 minutes. Additional information has been requested.
sore throat, cough, productive cough, nonproductive cough, body aches, diarrhea, post nasal drainage. starting on 10/11/21
7 y.o F with no significant PMH, no seizure history, no family h/o seizure presented to the hospital with multiple episodes of seizures. No recent illness. Patient was afebrile. Associated with occasional nausea and vomiting for the past 3 months. EEG significant for occipital spikes. MRI and CT normal.  Rest of the physical exam within normal limit. CBC, CMP normal. Currently patient is in normal state of health.
This non-serious spontaneous case, initially received from other non-health professional on 13-Nov-2018, concerns a 68-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 19-Oct-2018, the patient was administered FLUAD (TIV) [batch number: 250802, dose, route of administration, anatomical location and expiry date: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805516 was crossed linked to original cases 201804863 due to same reporter.
I felt really weak after my second dose.  I was very sore and tender to even move.  I was also stated to look puffy in my neck and chest area.  I was diagnosed with Myositis and Rhabdomyolysis.  I was hospitalized overnight to keep fluids flushing through me due to the muscle count found in my blood.
Delayed skin reaction: 6-7 cm round erythematous patch with raised borders developed surrounding injection site approx 8 days after injection. Pruritic but not painful. No blistering or purulence. Lasted 5-6 days then resolved spontaneously.
Information has been received from a registered pharmacist concerning an 80 year old female patient with a history of shingles, no other relevant medical history and no drug reactions or allergies, who on 14-AUG-2009 was vaccinated SQ with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot# 664122/0628Y). Concomitant therapy included "numerous medications". The pharmacist reported that on 02-AUG-2010, the patient returned to the pharmacy. The patient stated that since "past week or two" on approximately 19-JUL-2010, she had shingles on her face. It was unknown if treatment was needed. There were no laboratory tests or diagnostic studies performed. The outcome of the patient was not reported. The patient sought unspecified medical attention. Follow up information has been received from a Registered pharmacist concerning an 80 year old female retired patient with a history of shingles and no known drug reactions or allergies, who on 14-AUG-2009 was vaccinated SQ with a dose of ZOSTAVAX (Merck). The patient had the following illness at the time of vaccination: glaucoma, hypercholesterolemia and high blood pressure. The patient said that she had a "persistent" shingles and rash. Several months after the ZOSTAVAX (Merck), it "got worse" for a short time. The patient stated that it was happened before, but this time, it was not as severe as in the past. At the time of the report the outcome of the patient was recovered on an unspecified date. No further information is available.
Patient called clinic on 5/22/17 to report left hand swelling, shooting pain from left arm in to left palm between thumb and pointer finger which began the evening of 5/19/17. Pt. states within 7 hours after vaccination of TWINRIX she also developed a bruise on her left palm which continues to be bruised and painful. Pt. taking 500 mg of ADVIL daily.
Itchy; Red, bumpy skin around upper body; noticeable itchy, red, bumpyskin around my upper body, especiallyleft and right sides of upper body,neck, chest.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00(at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to cats, dusts and  mite allergy. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), ascorbic acid (VITAMIN C), cannabidiol (CBD OIL) and THC, all from unknown dates and for unspecified indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 23Mar2021, the patient underwent PCR(nasal swab) test and the result was negative. On 29Mar2021 at 13:00 6th day of vaccination, the patient experienced itchy, red, bumpy skin(skin lesions NOS) around upper body especially left and right sides of upper body, neck, chest. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the reported events which included benadryl once in the evening on 29Mar2021 and the symptoms were gone and returned mindly on the 30Mar2021.The patient took claritin instead for two extra days and stopped, all symptoms were gone. The clinical outcome of the event itchy, red, bumpy skin around upper body was recovered on unspecified date in 2021.   No follow-up attempts are needed. No further information is expected.
patient experienced a rash after her first injection; too late to get second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (patient experienced a rash after her first injection) and PRODUCT DOSE OMISSION ISSUE (too late to get second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (patient experienced a rash after her first injection) and PRODUCT DOSE OMISSION ISSUE (too late to get second vaccine). At the time of the report, VACCINATION SITE RASH (patient experienced a rash after her first injection) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (too late to get second vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided
11-26-12 PM itchiness at the vaccination site in afternoon / evening with little or no pain at the site. 11-27-12 in AM presented with cold symptoms and mild pain at the vaccination site muscular area of left arm. 11-27-12 in PM cold symptoms increased with some congestion and mild pain spreading from vaccination site through arm. Late PM muscular area pain increase and patient self medicated with 2 Advil. 11-28-12 AM called in sick to work, entire left arm and hand now has moderate muscular and nerve type pain, headache and tiredness present. 11-28-12 PM moderate muscular and nerve type pain on left arm increase and muscular pain started to spread across left side pectoral and into trapezius muscles with continued tiredness and headache. Planned to seek urgent care if pain did not subside, however, self medicated with 4 Advil and slept for 2 hours. Felt better when awakening. 11-29-12 AM returned to work but still felt bad with slight headache, tiredness and moderate muscular and nerve type pain on left arm. 11-30-12 felt better.
feeling very achy; the injection site is tender and sore; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 06-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feeling very achy), INJECTION SITE PAIN (the injection site is tender and sore) and NAUSEA (nausea) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included OXCARBAZEPINE for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (feeling very achy), INJECTION SITE PAIN (the injection site is tender and sore) and NAUSEA (nausea). At the time of the report, PAIN (feeling very achy), INJECTION SITE PAIN (the injection site is tender and sore) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Adverse events including lethargy, diaphoresis, pallor. Patient also had negative CT scan, lumbar puncture. Patient now has a left esophoria which was not present to this prior episode. Patient recovered it appears except for the esophoria. EEG and CT scan negative. No prior vaccine effects.  6/19/06 Records received which reveal patient experienced diaphoresis, cold body temp, poor responsiveness 1 hr 15 min s/p vax.  Birth hx: Mother was Grp B strep + & is a smoker.  PMH: excellent health but had low grade temp w/normal CBC on 4/31/06.  Initial ER dx w/vaccine associated event.  Transferred to larger hospital.  PCP records received 7/3/06 included hospital records from that hospital which revealed WBC on admit 19.1.  D/C from hospital on 5/25 & returned to PCP on 5/26 revealed patient was still not back to normal w/vomiting, diarrhea, low grade fever & starring episodes w/some regression re: reflexes.  By 5/30, child had returned to normal except for esotropia which did eventually resolve/ss
entire left upper arm is red after the vaccine was given (12/4/07) with darker red area where it was more swollen yesterday.  Immunization site noted in center of the erythematous area. Given Benadryl by mother. Advised cold compresses.
Vasculitis - waist down lower extremities 2/10/14 spread to arms by 2/11/14 pm.
Patient reports approximately 45 minutes after administration of the vaccine she developed a metallic taste in her mouth, followed by tingling and numbness in her lips, tongue, and tingling in her throat. She reports she took Benadryl sometime after this, and then eventually the sensation and taste resolved.
Pt developed dizziness, followed by headaches, then fatigue and body aches/myalgias,  Abdominal pain also developed. these symptoms persisted for 4+ months.  Symptoms were debilitating at times, causing her to miss a lot of school. Pt denied any preceeding viral illness. Symptoms began after the first dose, but worsened after the second dose of the vaccine. Labs showed  mild iron deficiency anemia, iron was supplemented with improvement in iron stores.  ESR was also elevated and remained elevated as of a few weeks ago. At this point many symptoms have improve, but she still reports fatigue with myalgias/arthralgias. Neurology evaluated with normal brain MRI. She has been referred to rheumatology. Her clinical picture is most consistent with a Chronic Fatigue Syndrome, which we suspect could have been triggered by the vaccinations.
Very swollen upper arm, red like a lobster. Swollen like a balloon. Treated with cephalexin, prednisone and BENADRYL.
Always have had regular cycles- never missed a period unless pregnant, never issues with infertility. I have 4 children. After receiving my first dose of Covid-19 vaccination, I had a heavy menstrual cycle. After the 2nd dose- I had 1 very light day of spotting instead of a normal menstrual period. The second following month, again, I had only one day of light spotting. I am now on my 3rd month and have had no menstrual cycle at all. I am not pregnant. The only change is the Covid-19 vaccine.
Had pneumonia vaccine on 10/17/2006 states was sore that evening. Noticed the following day red streaks near vaccine. On 10/19 states, has several blotches on front and back of arm.
Erythema multiforme (minor) - tx = SOLU MEDROL 125mg MEDROL dose pak cetirizine 10mg ranitidine 150mg. See notes.
Angina-type pains on left side; First dose on 13 Feb 2021 and refused to take second dose because headaches continued for about 3 weeks.; Shooting pain in the back of their head, had more headaches than normal/constant and unusual headaches in the back of my head; This spontaneous case was reported by a physician and describes the occurrence of CHEST PAIN (Angina-type pains on left side), PRODUCT DOSE OMISSION ISSUE (First dose on 13 Feb 2021 and refused to take second dose because headaches continued for about 3 weeks.) and HEADACHE (Shooting pain in the back of their head, had more headaches than normal/constant and unusual headaches in the back of my head) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Heart disease, unspecified. Concurrent medical conditions included Breast cancer. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEADACHE (Shooting pain in the back of their head, had more headaches than normal/constant and unusual headaches in the back of my head). On an unknown date, the patient experienced CHEST PAIN (Angina-type pains on left side) and PRODUCT DOSE OMISSION ISSUE (First dose on 13 Feb 2021 and refused to take second dose because headaches continued for about 3 weeks.). The patient was treated with ACETAMINOPHEN for Headache, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form once a day. At the time of the report, CHEST PAIN (Angina-type pains on left side) and PRODUCT DOSE OMISSION ISSUE (First dose on 13 Feb 2021 and refused to take second dose because headaches continued for about 3 weeks.) outcome was unknown and HEADACHE (Shooting pain in the back of their head, had more headaches than normal/constant and unusual headaches in the back of my head) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jul-2021: Significant Follow up; event outcome provided and denied second dose.
Patient presented for routine follow up visit with her PCP.  Patient was now age 65 and doctor ordered a Prevnar 13 vaccination for patient.  Nurse administered a PPSV 23 vaccine instead.  Patient had a previous dose of PPSV 23 on 09/14/2018.  No adverse reactions noted.
In November 2022 I noticed swelling and joint pain in my hands, feet and ankles. It then led to my fingers, wrists and shoulder joints. In December I saw my doctor and received an anti-inflammatory and it did not help. In January, I received methotrexate from a rheumatologist, and it helped. I was diagnosed in February with rheumatoid arthritis. Currently I am on MEDROL.
18 hours after the shot patient had muscle aches, congestion, and lethargy. arm pit on the left side was tender and swollen. Sore throat began 36 hours after vaccine, congestion and lethargy continued to worsen. 72 hours later the symptoms persist.
Information has been received from a female consumer who in 1997 was vaccinated with RECOMBIVAX HB.  In 1997 the consumer's arm became sore after receiving three doses of RECOMBIVAX HB.  It is unknown if the consumer sought medical attention.  At the time of the report, the outcome of the patient was unknown.  The consumer also reported that she has experienced arm soreness after receiving hepatitis A virus vaccine inactivated (MSD) (WAES # 0911USA04201).  Additional information has been requested.
Got nervous feeling; Allergic reaction to bee sting; rash of heat from her neck up to her head; noticed a feeling of needing to swallow and figured out it was just a knee jerk reaction to make sure she can swallow/still having the swallowing; Congested head, head felt congested, not like pressure; Fingertips a little numb and tingling; Fingertips a little numb and tingling; This is a spontaneous report from a contactable consumers (one is the patient). A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL9269), via an unspecified route of administration on 03Feb2021 at 10:40 at a single dose on the right arm for COVID-19 immunization, ibuprofen (manufactured by other company, strength: 200 mg, lot number: 7AE1784B, expiry date: Nov2018), oral from an unspecified date and ongoing at 400 mg, as needed for an unspecified indication, hydrochlorothiazide (strength: 25 mg), oral from an unspecified date and ongoing at 25 mg, once a day (about 8am) for high blood pressure, and valsartan (strength: 160 mg, expiration date: 11Nov2021), oral from an unspecified date and ongoing at 160 mg, once a day (about 8am) for high blood pressure. Medical history included ongoing high blood pressure. The patient's concomitant medications were not reported. The patient previously took flu shot about 15-20 years ago for immunization and experienced swelling. On 03Feb2021, patient received the vaccine. When going home, she noticed all of a sudden a rash of heat from her neck up to her head. Figured it was not a problem to have a little reaction and thought nothing of it. She had a cup of coffee this morning and not a lot of water, so she started drinking water and had 3 bottles. After the heat passed she noticed a feeling of needing to swallow and figured out it was just a knee jerk reaction to make sure she can swallow. She is still having the swallowing and is continuing to drink water even at home. She also congested head, head felt congested, but not like pressure. She does not get headaches so she guesses she is getting this instead of a headache. She noticed her fingertips feel a little numb and tingling, but overall feels okay. She mentioned that on an unspecified date, she just got this nervous feeling and had allergic reaction to bee sting. Mentioned that her husband and brother in law got the shot and were feeling fine. No further details provided. The action taken in response to the events for ibuprofen was dose not changed , for hydrochlorothiazide was dose not changed, and for valsartan was dose not changed. The outcome of the event rash of heat from her neck up to her head was recovering; event got nervous feeling was unknown, while the other events was not recovered.
Extreme chills and shaking - 5 hours,  nausea,  aches,  headache, fatigue, cough, shortness of breath ,  no appetite after shaking stopped.
admitted on 10/10/2021 for shortness of breath and cough, chest congestion of 10 days duration.  He tested positive for COVID-19.  CTA chest was done it ruled out a PE but showed significant emphysematous changes.  He was started on IV Decadron.  He was out of window for remdesivir.  He required minimal oxygen initially 2 liters/minute. He was discharged home with new onset home O2.